tailieuchung - Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: A network meta-analysis

Đang chuẩn bị liên kết để tải về tài liệu:
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: A network meta-analysis

Thường Kiệt 29 12 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Long-term antiviral treatments are associated with a significantly lower hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients by reducing HBV DNA concentrations. |

Đang chuẩn bị liên kết để tải về tài liệu:
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: A network meta-analysis

Long-term antiviral treatments are associated with a significantly lower hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients by reducing HBV DNA concentrations. |

The effect of TNF-α - 308 G>A polymorphism alters the risk of hepatocellular carcinoma

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review

Comparative effectiveness of angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study

A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma

LIVER TUMORS EPIDEMIOLOGY, DIAGNOSIS, PREVENTION AND TREATMENT

Correlation of chitinase 3-like 1 single nucleotide polymorphisms with hepatocellular carcinoma in Taiwan

Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma

A rare CHD5 haplotype and its interactions with environmental factors predicting hepatocellular carcinoma risk

Đang chuẩn bị liên kết để tải về tài liệu: Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: A network meta-analysis

Long-term antiviral treatments are associated with a significantly lower hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients by reducing HBV DNA concentrations. |

The effect of TNF-α - 308 G>A polymorphism alters the risk of hepatocellular carcinoma

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review

Comparative effectiveness of angiotensinconverting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: A nationwide high-risk cohort study

A differential risk assessment and decision model for Transarterial chemoembolization in hepatocellular carcinoma based on hepatic function

Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma

A gene-based risk score model for predicting recurrence-free survival in patients with hepatocellular carcinoma

LIVER TUMORS EPIDEMIOLOGY, DIAGNOSIS, PREVENTION AND TREATMENT

Correlation of chitinase 3-like 1 single nucleotide polymorphisms with hepatocellular carcinoma in Taiwan

Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma

A rare CHD5 haplotype and its interactions with environmental factors predicting hepatocellular carcinoma risk

Đang chuẩn bị liên kết để tải về tài liệu:
Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: A network meta-analysis